Phase 2 Study of the Safety and Antitumor Activity of Apalutamide (ARN-509), a Potent Androgen Receptor Antagonist, in the High-risk Nonmetastatic Castration-resistant Prostate Cancer Cohort.

Use of androgen deprivation therapy as salvage treatment after primary therapy for clinically localized prostate cancer.

Evaluation of the Tobacco Heating System 2.2. Part 1: Description of the system and the scientific assessment program.

MIMEAnTo: profiling functional RNA in mutational interference mapping experiments.

Clinical approach to diffuse large B cell lymphoma.

Inferring HIV-1 Transmission Dynamics in Germany From Recently Transmitted Viruses.

Mental Fatigue: Impairment of Technical Performance in Small-Sided Soccer Games.

Acquired resistance to venetoclax (ABT-199) in t(14;18) positive lymphoma cells.

Evolution: Velvet Worm Biogeography.

Antibody Drug Conjugates (ADCs): Changing the Treatment Landscape of Lymphoma.